Bioscience Equity Partners is an international investment banking - financial services firm focusing exclusively on compelling Med Tech and Biosciences investment themes and ventures.

We are headquartered in Sydney Australia and have a subsidiary in New York, Bioscience Equity Partners Inc., in London, Bioscience Equity Partners Limited and also operate in the Asia Pacific region through our Hong Kong subsidiary Bioscience Equity Partners Ltd.
Bioscience and medical technologies are constantly changing and growing, and Bioscience Equity Partners is providing bespoke financial solutions for our clients in this dynamic era. Our tailored financial services enable clients to focus on addressing unmet medical needs. We are committed to creating better experiences together for creating therapeutics and diagnostics of the future.
Bioscience & MedTech
Capital Markets
Mergers and Acquisitions
Venture Capital
Equity Research
Investor Relations

03

Partners

03

Offices

13

IPOs

100%

Success

We are exclusively backed by a European family office owned fund, Antisoma Venture Capital Fund, which understands biosciences and medical technologies better than anyone else in the PE and VC space. The capital of this fund has been generated by the family office's active bioscience investments globally since 1995.

AVCF Logo_v1_Tagline.png